ID

32560

Descrizione

Study ID: 109059 Clinical Study ID: OTB109059 Study Title: TXA107979:A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men with Premature Ejaculation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01021553 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: epelsiban Trade Name: Study Indication: Premature Ejaculation

Keywords

versioni (1)
  1. 2018-11-06 2018-11-06 -
Titolare del copyright

GlaxoSmithKline

Caricato su

6 november 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Delay in IELT, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK557296 in Men with Premature Ejaculation, 109059

Inglese

Logs and Repeats

1 moduli  
  1. StudyEvent: ODM
    1. Logs and Repeats
Date of visit/assessment
Descrizione

Date of visit/assessment

Alias
UMLS CUI-1
C1320303
UMLS CUI-2
C2985720
Date of visit/assessment
Descrizione

Date of visit, Assessment date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C1320303
UMLS CUI [1,2]
C2985720
Adverse Event/Concomitant Medication/Repeat Assessment
Descrizione

Adverse Event/Concomitant Medication/Repeat Assessment

Alias
UMLS CUI-1
C0877248
UMLS CUI-2
C2347852
UMLS CUI-3
C1516048
Were any concomitant medications taken by the subject during the study?
Descrizione

Concomitant Agent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2347852
Did the subject experience any non-serious adverse events during the study?
Descrizione

Non-serious Adverse Event

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1518404
Did the subject experience any serious adverse events during the study?
Descrizione

Serious Adverse Event

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1519255
Does the subject have any past or current Medical Conditions?
Descrizione

Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0012634
Has the subject had any Medical/Surgical Procedures?
Descrizione

Surgical and medical procedures

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1948041
Were any abnormal, clinically significant ECG measurements recorded for this subject during the study?
Descrizione

Electrocardiogram abnormal

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0522055
Were any repeat ECGs performed?
Descrizione

Electrocardiogram, Repeat

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013798
UMLS CUI [1,2]
C0205341
Were any repeat vital signs recorded?
Descrizione

Vital Signs, Repeat

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0518766
UMLS CUI [1,2]
C0205341
Were any repeat PK blood samples taken?
Descrizione

Pharmacokinetic study, Blood sample taken, Repeat

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0201734
UMLS CUI [1,2]
C1277698
UMLS CUI [1,3]
C0205341
Were there any Unscheduled Investigational Product dispensed or returned?
Descrizione

Experimental drug, Dispensing medication; Experimental drug, Return

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0947323
UMLS CUI [2,1]
C0304229
UMLS CUI [2,2]
C0332156
Liver Event
Descrizione

Liver Event

Alias
UMLS CUI-1
C0023884
UMLS CUI-2
C0877248
Have liver chemistry results reached or exceeded protocol-defined investigational product stopping criteria?
Descrizione

Liver Function, Chemistry, Laboratory test finding

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0008000
UMLS CUI [1,3]
C0587081
Ritorna all'inizio della pagina

Similar models

Logs and Repeats

1 moduli
  1. StudyEvent: ODM
    1. Logs and Repeats
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Date of visit/assessment
C1320303 (UMLS CUI-1)
C2985720 (UMLS CUI-2)
Date of visit, Assessment date
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1,1])
C2985720 (UMLS CUI [1,2])
Item Group
Adverse Event/Concomitant Medication/Repeat Assessment
C0877248 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
C1516048 (UMLS CUI-3)
Concomitant Agent
Item
Were any concomitant medications taken by the subject during the study?
boolean
C2347852 (UMLS CUI [1])
Non-serious Adverse Event
Item
Did the subject experience any non-serious adverse events during the study?
boolean
C1518404 (UMLS CUI [1])
Serious Adverse Event
Item
Did the subject experience any serious adverse events during the study?
boolean
C1519255 (UMLS CUI [1])
Disease
Item
Does the subject have any past or current Medical Conditions?
boolean
C0012634 (UMLS CUI [1])
Surgical and medical procedures
Item
Has the subject had any Medical/Surgical Procedures?
boolean
C1948041 (UMLS CUI [1])
Electrocardiogram abnormal
Item
Were any abnormal, clinically significant ECG measurements recorded for this subject during the study?
boolean
C0522055 (UMLS CUI [1])
Electrocardiogram, Repeat
Item
Were any repeat ECGs performed?
boolean
C0013798 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
Vital Signs, Repeat
Item
Were any repeat vital signs recorded?
boolean
C0518766 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
Pharmacokinetic study, Blood sample taken, Repeat
Item
Were any repeat PK blood samples taken?
boolean
C0201734 (UMLS CUI [1,1])
C1277698 (UMLS CUI [1,2])
C0205341 (UMLS CUI [1,3])
Experimental drug, Dispensing medication; Experimental drug, Return
Item
Were there any Unscheduled Investigational Product dispensed or returned?
boolean
C0304229 (UMLS CUI [1,1])
C0947323 (UMLS CUI [1,2])
C0304229 (UMLS CUI [2,1])
C0332156 (UMLS CUI [2,2])
Item Group
Liver Event
C0023884 (UMLS CUI-1)
C0877248 (UMLS CUI-2)
Liver Function, Chemistry, Laboratory test finding
Item
Have liver chemistry results reached or exceeded protocol-defined investigational product stopping criteria?
boolean
C0232741 (UMLS CUI [1,1])
C0008000 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial